The high expression instead of mutation of p53 is predictive of overall survival in patients with esophageal squamous‐cell carcinoma: a meta‐analysis

Esophageal squamous‐cell carcinoma (ESCC) is one of the deadliest cancers where biomarkers are needed for assist guiding management. We performed a meta‐analysis to clarify the prognostic value of p53 high expression and TP53 mutations, which remain controversial for decades in patients with ESCC. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ziran, Wang, Pan, Gao, Yibo, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269704/
https://www.ncbi.nlm.nih.gov/pubmed/27882726
http://dx.doi.org/10.1002/cam4.945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269704/
https://www.ncbi.nlm.nih.gov/pubmed/27882726
http://dx.doi.org/10.1002/cam4.945

Ejemplares similares